NEOGEN CORP
corporate_fare Company Profile
NEOGEN CORP (NASDAQ:NEOG) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 10 items for NEOG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-29, rated 8/10. Across its 10 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for NEOG spans 10-K, 8-K, 10-Q.
Recent high-impact activity:
- FDA Warning Letter: Neogen's Hycoat Linked to 20 Horse Deaths, Contamination Found
- Annual Report Highlights Significant Net Loss Reduction, Internal Control Remediation, and Debt Reduction
- Neogen Delivers 4.3% Core Growth in Q4, Sets FY2027 Outlook
- Neogen Reports Wider Q3 GAAP Loss Amid Strategic Divestitures & Persistent Control Weaknesses
- Neogen Beats Q3 Earnings & Revenue, Boosts Full-Year Outlook
Financial Snapshot
Short Interest & Short Volume
4.53 days to coverFINRA reported short interest of 11,168,684 shares in NEOG as of the September 15, 2026 settlement, a 5.5% increase from the prior period — about 4.5 days to cover at its recent average daily volume. On October 2, 2026, 54.6% of NEOG volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.